コーパス検索結果 (1語後でソート)
  通し番号をクリックするとPubMedの該当ページを表示します
  
   1 subset of 4-repeat tau-containing lesions in Pick disease.                                           
     2 herited human disorder types A and B Niemann-Pick disease.                                           
     3 nctional and the levels of which increase in Pick disease.                                           
     4 ary function in patients with type B Niemann-Pick disease.                                           
     5 ck-out (ASMKO) mouse model of Type A Niemann-Pick disease.                                           
     6 O) mice are a model of types A and B Niemann-Pick disease.                                           
     7 (acid sphingomyelinase, deficient in Niemann-Pick disease A-B) was enhanced to all affected organs by
  
  
    10 g Alzheimer's disease, tangle-only dementia, Pick disease, argyrophilic grain disease (AGD), progress
    11 ude Alzheimer disease, tangle-only dementia, Pick disease, argyrophilic grain disease, chronic trauma
  
  
  
  
  
  
  
  
    20 both the neuronal and glial tau pathology of Pick disease, it detects only the neuronal pathology in 
    21 e-predominant senile dementia (TPSD; n = 5), Pick disease (n = 4), familial AD (FAD; n = 2; PSEN1 p.G
  
  
  
  
  
  
  
  
  
  
  
  
    34  in the lipid storage disease type A Niemann-Pick disease (NPD-A), mimicked in mice by interruption o
  
    36 ough studies using lymphoblasts from Niemann-Pick disease patients or acid sphingomyelinase (ASMase)-
  
  
  
    40 tau are prominent in Alzheimer disease (AD), Pick disease, progressive supranuclear palsy (PSP) and c
    41 l tau in post-mortem human brain tissue from Pick disease, progressive supranuclear palsy, corticobas
  
    43 ell lines derived from patients with Niemann-Pick disease that lack acidic sphingomyelinase activity.
    44     Cells from both human and murine Niemann-Pick disease type A have been studied to assess the role
  
    46 s, neuronal 2, CLN2), Fabry, Farber, Niemann-Pick disease type A, Sanfilippo type B (mucopolysacchari
  
  
    49 icking as well as siRNA knockdown of Niemann-Pick disease type C (NPC) 1 and NPC2 also cause inhibiti
  
  
  
  
  
  
  
  
  
  
  
    61  and lysosomes of cells derived from Niemann-Pick disease type C (NPC) patients and demonstrate a gre
    62 ingolipid storage diseases, includes Niemann-Pick disease type C (NPC), caused predominantly (95%) by
  
  
    65 rapeutic effects in animal models of Niemann-Pick disease type C and several other neurodegenerative 
    66 nsport deficiency in patient-derived Niemann-Pick disease type C fibroblasts by fluorescence as well 
    67  the late endosomal membrane protein Niemann-Pick disease type C protein 1 (NPC1) arising during earl
  
  
    70 een Juno and the cholesterol-binding Niemann-Pick disease type C1 protein (NPC1) suggests how the mod
    71  was coimmunoprecipitated with NPC1 (Niemann-Pick disease type C1), an endocytic regulator of LDL tra
    72 ntially reduced in cells depleted of Niemann-Pick disease type C1, a lysosomal protein required for c
  
  
  
  
  
    78 ucodystrophy, mucolipidosis type IV, Niemann-Pick disease (types A, B, and C), and sphingolipid-activ
    79 s; mean age, 23.3 years) with type B Niemann-Pick disease was evaluated with imaging and pulmonary fu
    80 was commonly associated with nfvPPA, whereas Pick disease was observed in a minority of subjects acro
    81 sts from patients with types A and B Niemann-Pick disease, which are known to lack lysosomal SMase ac
    82 logy and ultrastructural features of Niemann-Pick disease, with confirmatory findings in biochemical 
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。